Siemens Healthineers intends to close its Fast Track Diagnostics unit. The company announced this on Monday this week. The PCR division is affected. Approximately 90 employees, primarily based in Luxembourg, are also affected. Siemens Healthineers offers in-vitro diagnostic test solutions for almost every clinical setting. Its central laboratory analyzers are used in research laboratories, clinical laboratories of local community hospitals, independent specialized laboratories, and the world's largest reference laboratories.

Siemens Healthineers and City Cancer Challenge (C/Can) are expanding the geographical and technological scope of their partnership long-term. They are building on their existing collaboration to enable faster cancer diagnosis and treatment and increase the chances of survival for patients in low- and middle-income countries. The globally active medical technology company Siemens Healthineers is providing a sum of five million Swiss francs over the next five years to close gaps within the patient pathway from the first cancer symptoms through diagnosis to treatment, improve access to high-quality cancer care, and enhance gender health equity. C/Can works with urban stakeholders from the public and private sectors to improve access to cancer care from the ground up in low- and middle-income countries. The organization currently supports projects in 14 cities in North and...